BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20607366)

  • 1. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.
    Merino G; Perez M; Real R; Egido E; Prieto JG; Alvarez AI
    Pharm Res; 2010 Oct; 27(10):2098-105. PubMed ID: 20607366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones.
    Pérez M; Real R; Mendoza G; Merino G; Prieto JG; Alvarez AI
    J Vet Pharmacol Ther; 2009 Oct; 32(5):498-502. PubMed ID: 19754918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep.
    Perez M; Otero JA; Barrera B; Prieto JG; Merino G; Alvarez AI
    Vet J; 2013 May; 196(2):203-8. PubMed ID: 23083838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
    Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse.
    Zhang Y; Wang H; Unadkat JD; Mao Q
    Drug Metab Dispos; 2007 Dec; 35(12):2154-8. PubMed ID: 17785426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice.
    Álvarez AI; Vallejo F; Barrera B; Merino G; Prieto JG; Tomás-Barberán F; Espín JC
    Drug Metab Dispos; 2011 Nov; 39(11):2008-12. PubMed ID: 21828252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
    González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G
    Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Food-Derived Isoflavone Sulfates as Inhibition Markers for Intestinal Breast Cancer Resistance Proteins.
    Agustina R; Masuo Y; Kido Y; Shinoda K; Ishimoto T; Kato Y
    Drug Metab Dispos; 2021 Nov; 49(11):972-984. PubMed ID: 34413161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pregnancy on nitrofurantoin disposition in mice.
    Zhang Y; Zhou L; Unadkat JD; Mao Q
    J Pharm Sci; 2009 Nov; 98(11):4306-15. PubMed ID: 19422048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.
    Wang L; Leggas M; Goswami M; Empey PE; McNamara PJ
    Drug Metab Dispos; 2008 Dec; 36(12):2591-6. PubMed ID: 18799806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of monepantel secretion into milk by soy isoflavones.
    Gunes Y; Okyar A; Krajcsi P; Fekete Z; Ustuner O
    J Vet Pharmacol Ther; 2023 May; 46(3):185-194. PubMed ID: 36448496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
    Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.
    Adkison KK; Vaidya SS; Lee DY; Koo SH; Li L; Mehta AA; Gross AS; Polli JW; Lou Y; Lee EJ
    Br J Clin Pharmacol; 2008 Aug; 66(2):233-9. PubMed ID: 18429968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
    Merino G; Alvarez AI; Pulido MM; Molina AJ; Schinkel AH; Prieto JG
    Drug Metab Dispos; 2006 Apr; 34(4):690-5. PubMed ID: 16434544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
    van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
    Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.
    Wright JA; Haslam IS; Coleman T; Simmons NL
    Eur J Pharmacol; 2011 Dec; 672(1-3):70-6. PubMed ID: 22004608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.
    Yang Z; Zhu W; Gao S; Yin T; Jiang W; Hu M
    Drug Metab Dispos; 2012 Oct; 40(10):1883-93. PubMed ID: 22736306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
    Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
    Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.
    Breedveld P; Pluim D; Cipriani G; Wielinga P; van Tellingen O; Schinkel AH; Schellens JH
    Cancer Res; 2005 Apr; 65(7):2577-82. PubMed ID: 15805252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2.
    Wang X; Morris ME
    Drug Metab Dispos; 2007 Feb; 35(2):268-74. PubMed ID: 17093006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.